KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for BioNTech SE (BNTX) over the last 7 years, with Q3 2025 value amounting to 0.41%.

  • BioNTech SE's Return on Invested Capital fell 2500.0% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41%, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of 1.44% for FY2024, which is 25100.0% down from last year.
  • Per BioNTech SE's latest filing, its Return on Invested Capital stood at 0.41% for Q3 2025, which was down 2500.0% from 0.44% recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Return on Invested Capital ranged from a high of 887355.84% in Q2 2021 and a low of 1.47% during Q1 2024
  • For the 5-year period, BioNTech SE's Return on Invested Capital averaged around 91115.63%, with its median value being 0.7% (2023).
  • As far as peak fluctuations go, BioNTech SE's Return on Invested Capital surged by 2000000000bps in 2021, and later tumbled by 2000000000bps in 2022.
  • BioNTech SE's Return on Invested Capital (Quarter) stood at 1.54% in 2021, then dropped by -29bps to 1.1% in 2022, then tumbled by -59bps to 0.45% in 2023, then crashed by -294bps to 0.87% in 2024, then surged by 53bps to 0.41% in 2025.
  • Its Return on Invested Capital stands at 0.41% for Q3 2025, versus 0.44% for Q2 2025 and 0.65% for Q1 2025.